Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore the benefits of using Cash App for savings. This platform offers unique features that can help you grow your funds effectively.
24,982 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
CoreWeave’s stock suffers another long selloff as investors weigh debt exposure against growth in the AI cloud market...
MBA researchers project 2025 real GDP around 2.5% with consumer spending staying resilient, while FHA delinquencies r...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
Ford and GM reported solid profits driven by SUVs in 2025, but a cloud of EV costs, tariffs and trade policy question...
Analysts upgrade CrowdStrike ahead of earnings, citing modest guidance risk and a software sector pullback that has w...
Archer Aviation counters Jobs, accusing Joby of government misrepresentation and hidden foreign ties. The ongoing dis...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
Micron Technology is set to release quarterly results after the bell, with investors hoping for a blowout fueled by A...
The latest inflation report out shows retirees still face rising essentials even as COLA gains ease. Here's what that...
Murphy Oil has surged about 48% in the past year, with shares trading near a 52-week high as Vietnam offshore project...
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...